Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengcheng Gong

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Clinical Breast Cancer|March 9, 2019
Fulvestrant 500 mg Versus Exemestane in Postmenopausal Women With Metastatic Breast Cancer Resistant to Adjuvant Nonsteroidal Aromatase Inhibitors in Clinical Practice: A Multicenter Retrospective StudyYizhao Xie, Yi Li, Yinbin Zhang, et al.
Eclinicalmedicine|November 17, 2025
Efficacy and safety of ARX788 for individuals with HER2-positive breast cancer and brain metastases (ACE-Breast-06): a single-arm, phase 2 trial in ChinaTing Li, Mingxi Lin, Biyun Wang, et al.
Frontiers in Oncology|July 23, 2020
Characterizations of Cancer Gene Mutations in Chinese Metastatic Breast Cancer PatientsZhonghua Tao, Ting Li, Zhe Feng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2026
Phase II Clinical Study of Adebrelimab and Bevacizumab Combined With Cisplatin/Carboplatin in Patients With Triple-Negative Breast Cancer With Brain Metastases (ABC Study)Ting Li, Teng Zhou, Biyun Wang, et al.
Therapeutic Advances in Medical Oncology|July 22, 2021
Real-world effectiveness of eribulin in heavily pretreated patients with metastatic breast cancer in China: a multicenter retrospective studyYannan Zhao, Ning Xie, Wei Li, et al.
Nature Communications|November 3, 2025
Site-specific ligase-dependent conjugation with ring-opening linker improves safety and stability of HER2-targeting ADCsLei Huang, Gang Qin, Chengcheng Gong, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Clinical Breast Cancer|March 9, 2019
Fulvestrant 500 mg Versus Exemestane in Postmenopausal Women With Metastatic Breast Cancer Resistant to Adjuvant Nonsteroidal Aromatase Inhibitors in Clinical Practice: A Multicenter Retrospective StudyYizhao Xie, Yi Li, Yinbin Zhang, et al.
Eclinicalmedicine|November 17, 2025
Efficacy and safety of ARX788 for individuals with HER2-positive breast cancer and brain metastases (ACE-Breast-06): a single-arm, phase 2 trial in ChinaTing Li, Mingxi Lin, Biyun Wang, et al.
Frontiers in Oncology|July 23, 2020
Characterizations of Cancer Gene Mutations in Chinese Metastatic Breast Cancer PatientsZhonghua Tao, Ting Li, Zhe Feng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2026
Phase II Clinical Study of Adebrelimab and Bevacizumab Combined With Cisplatin/Carboplatin in Patients With Triple-Negative Breast Cancer With Brain Metastases (ABC Study)Ting Li, Teng Zhou, Biyun Wang, et al.
Therapeutic Advances in Medical Oncology|July 22, 2021
Real-world effectiveness of eribulin in heavily pretreated patients with metastatic breast cancer in China: a multicenter retrospective studyYannan Zhao, Ning Xie, Wei Li, et al.
Nature Communications|November 3, 2025
Site-specific ligase-dependent conjugation with ring-opening linker improves safety and stability of HER2-targeting ADCsLei Huang, Gang Qin, Chengcheng Gong, et al.
Pageof 5